Key facts
- In February 2025, 821 measles cases were reported by 14 countries. Sixteen countries reported zero cases.
- Through its epidemic intelligence activities, ECDC has identified an additional 3 012 new cases from 15 EU/EEA countries.
- Overall, four measles-related deaths have been reported in the EU/EEA in 2025, all of them in Romania.
- There has been high measles activity overall in the EU/EEA over the last 12 months; however, the situation varies by country. Some countries have reported large and/or ongoing outbreaks, while others have reported either no sustained transmission or very low transmission.
- Outbreaks associated with imported measles cases have been reported by EU countries.
- Relevant epidemiological updates are available for WHO regions, the United States, and Canada.
Overview
In February 2025, 821 measles cases were reported by 14 countries. Sixteen countries reported zero cases. In the most recent 12-month period, from 1 March 2024 to 28 February 2025, 30 EU/EEA Member States reported a total of 28 791 cases of measles.
Between 1 March 2024 and 28 February 2025, of the 28 791 cases with known age, 12 816 (44.5%) were in children under five years old; and 7 880 (27.4%) cases were aged 15 years or older.
The highest notification rates were observed in infants under one year of age (928.4 cases per million) and children aged one to four years (542.6 cases per million). Of 26 669 cases (100.0% of all cases) with a known age and vaccination status, 22 992 (86.2%) were unvaccinated, 2 378 (8.9%) were vaccinated with one dose of a measles-containing vaccine, 1 213 (4.5%) were vaccinated with two or more doses, and 50 (0.2%) were vaccinated with an unknown number of doses.
Fourteen deaths (case fatality rate (CFR): 0.0) attributable to measles were reported to ECDC during the 12-month period by Romania (14) (Figure 4). Detailed data are available in ECDC's Surveillance Atlas of Infectious Diseases.
Complementary epidemic intelligence surveillance, with data collection conducted on 15 April 2025 from official and unofficial public sources, identified 3 012 measles cases reported since the last monthly update on 6 March 2025. Cases were reported in 15 EU/EEA countries: Austria, Bulgaria, Cyprus, Czechia, France, Germany, Hungary, Lithuania, the Netherlands, Norway, Poland, Portugal, Romania, Spain, and Sweden.
Disclaimer: The monthly measles report published in the CDTR provides the most recent data on cases and outbreaks based on information made publicly available by the national public health authorities or the media. Sometimes this information is made available retrospectively. This report is a supplement to ECDC’s monthly measles and rubella monitoring report, based on data routinely submitted by 30 EU/EEA countries to TESSy and EpiPulse. Data presented in the two monthly reports may differ.
Epidemiological summary for EU/EEA countries with relevant epidemic intelligence updates:
Austria reported 78 confirmed measles cases in 2025 and as of 9 April 2025, an increase of 27 cases since 5 March 2025.
Bulgaria reported one measles case in 2025 and as of 15 April 2025.
Cyprus media, citing official sources, report a measles outbreak following a cluster of that was identified at a nursery in March. As of 20 March 2025, a total of nine cases (eight children and one teacher) were reported.
Czechia reported nine cases in 2025 as of 1 April 2025.
France reported 180 measles cases in 2025 and as of 14 March 2025. Of these, 82 (46%) were hospitalised (6 in intensive care) and 35 (20%) had complications. Most cases (71%) were unvaccinated.
Since the beginning of the year, there has been a notable increase in the number of imported cases of measles, particularly from Morocco: 41 imported cases or cases linked to an importation from Morocco have been reported since the beginning of the year in several regions in France compared to 26 cases in 2024.
Germany reported 85 measles cases in 2025 and, as of 15 April 2025, an increase of 44 cases since 5 March 2025.
Hungary reported two cases of measles in 2025 as of 6 April 2025.
Lithuania reported two cases in 2025 as of 26 March 2025.
The Netherlands reported 251 measles cases in 2025 and as of 9 April 2025, an increase by 188 cases since 5 March 2025. There is no indication of a national outbreak. Clusters of measles cases have been detected among children linked to primary schools, with additional cases reported within households. In 2025, 26 cases were reported to have contracted measles in Morocco and three in Romania.
Norway reported two cases of measles in 2025 as of 15 April 2025, one in January and one in March.
Poland reported 34 measles cases in 2025 as of 31 March, an increase of 19 cases since 28 February 2025.
Portugal reported, according to media citing official sources, 11 measles cases in 2025 as of 8 April 2025. All cases were imported or linked to an imported case.
Romania reported 5 104 measles cases and four deaths in 2025 as of 31 March, an increase of 2 459 cases since 28 February 2025.
Spain reported 179 measles cases in 2025 as of 6 April 2025, an increase of 56 cases since 2 March 2025. Of reported cases, 57 (32%) were imported and 50 (39%) were linked to an imported case. Outbreaks have been reported in several parts of Spain.
Sweden reported three measles cases in 2025 and as of 15 April 2025.
Epidemiological summary for select countries outside of EU/EEA with relevant epidemic intelligence updates:
United States
As of 10 April 2025, the US CDC reported 712 confirmed measles cases in 2025, including two confirmed deaths (both in Texas) and one death under investigation in New Mexico.
Of the reported cases, 97% are unvaccinated or have unknown vaccination status; 70% are children 0–19 years (32% under 5 years). Hospitalisation was reported for 11% of the cases (79 of 712); most hospitalised individuals were children 0–19 years (65 cases, of which 45 were children under five years old). There have been seven outbreaks (defined as three or more cases) reported in 2025 in the US and 93% of the confirmed cases are outbreak-associated. The cases have been reported from 25 jurisdictions.
WHO issued Disease Outbreak News (DON) on 27 March 2025. Following declaration of elimination in 2000, the current measles outbreak in the US is considered an unusual event with a potential significant public health impact. WHO assesses the risk of measles in the Region of the Americas as high.
Canada
According to the most recent update on 11 April 2025, Canada has reported 731 measles cases (confirmed and probable) by 6 jurisdictions. Majority of the cases are reported in Ontario (656) and nearly all reported cases (722) are related to a multijurisdictional outbreak, which started in October 2024 in New Brunswick, then spread to Ontario with related cases detected in Alberta, Manitoba and Quebec.
Summary of measles cases reported by WHO regional offices
Increased measles activity has been reported globally. A total of 39 281 measles cases have been reported to the WHO Regional Offices in 2025 and as of 10 April 2025.
The WHO Regional Office for Europe (WHO/EUROPE) reported 6 841 measles cases in 2025. Most cases outside of EU/EEA were reported from Kyrgyzstan (2 970), Kazakhstan (397) and the Russian Federation (373).
The numbers provided to WHO for EU/EEA countries are from TESSy data, which are updated monthly and available on the ECDC Surveillance Atlas of Infectious Diseases. Due to differences in reporting times, the numbers may not correspond to the data from epidemic intelligence screening.
The WHO Regional Office for Africa (WHO AFRO) reported 10 623 measles cases in 2025. The highest numbers of cases were reported from Ethiopia (2 579), Nigeria (1 228), Niger (920) and Rwanda (817).
On 5 April 2025, the WHO Regional Office for the Americas (WHO PAHO) reported 1 589 confirmed cases of measles, including two deaths, by five countries: Canada (730), United States (712, including two deaths), Mexico (126), Argentina (18) and Brazil (3). This marks a substantial increase from 268 cases, including one death reported in February 2025, due to increasing numbers of cases in Canada and the US. In addition, media, quoting Ministry of Health, reported two cases of measles in Belize. Both cases are unvaccinated teenagers with travel history to Mexico.
The WHO Regional Office for South-East Asia (WHO SEARO) reported 5 498 measles cases. The highest numbers of cases were reported by India (4 388), Indonesia (666), Thailand (336), Nepal (101) and Bangladesh (5).
The WHO Regional Office for the Eastern Mediterranean (WHO EMRO) reported 12 897 measles cases in 2025. The highest number of cases were reported from Yemen (4 569), Afghanistan (4 182), Pakistan (2 799), Sudan (408) and Morocco (299).
The WHO Regional Office for the Western Pacific (WHO WPRO) reported 2 185 measles cases in 2025. The highest number of cases were reported from Philippines (766), China (577), Cambodia (544), Viet Nam (151), and Malaysia (104).
ECDC assessment
The overall number of measles cases in the EU/EEA increased steadily between June 2023 and March 2024 before decreasing between April 2024 and February 2025. Measles cases may continue to increase in the EU/EEA in the coming months, in line with measles observed seasonality. This is due to reported suboptimal vaccination coverage for measles-containing vaccines (MCV) in a number of EU/EEA countries, as well as a high probability of importation from areas experiencing high circulation. The majority of recently reported cases have acquired the disease within the reported country through community/local transmission, however cases related to international travel have been reported.
Actions
ECDC is monitoring the measles situation through its epidemic intelligence activities, which supplement monthly outputs with measles surveillance data from TESSy, routinely submitted by 30 EU/EEA countries.
As the number of cases is expected to rise in the near future, ECDC urges EU/EEA public health authorities to focus on the following areas:
- Close immunity gaps, achieve and maintain high vaccination coverage for MCV (>95% with the second dose). It is vital to ensure first and second dose vaccinations are administered on time as per national schedules among infants and children. It is also important to identify and vaccinate eligible individuals (for example, non-immune adolescents and adults) in immunisation catch-up programmes (as recommended by local and national authorities).
- Strive towards high-quality surveillance and adequate public health capacity, especially for early detection, diagnosis, response and control of outbreaks.
- Increase the clinical awareness of health professionals, including reminding them of the importance of checking individuals' vaccination status ahead of travel.
- Healthcare professionals should be fully vaccinated.
- Promote vaccine acceptance and uptake by employing specific risk communication strategies and identifying drivers of suboptimal MMR vaccine acceptance and uptake to ensure that tailored interventions are implemented in response.
- Address barriers and engage with under-served populations. Systemic barriers that impact vaccine uptake in under-served, isolated and difficult-to-reach populations need to be monitored and addressed with targeted strategies in order to reduce inequalities in vaccine uptake.
ECDC's latest advice on measles is available in the Threat Assessment Brief 'Measles on the rise in the EU/EEA: Considerations for a public health response', published in February 2024 and the conclusions remain valid. Additional information on the risk classification and ECDC recommendations can be found in this report.